SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (2029)1/24/1998 7:38:00 PM
From: Myron David Kor  Read Replies (3) of 7041
 
Thank you very much for forwarding a copy of E-Mail you received the other day re a Washington D.C. law firm. Apparently Asensio/Wexler or Wexler/Asensio has convinced an investigation
by Donald J. Enright at Finkelstein, Thompson and Loughran to
investigate Zonagen. The letter was put out by Thompson who states he is with a law firm that handles plaintiffs class action lawsuits in the securities field and other securities matters. The disclaimer is perhaps the most interesting part of the e-mail. I guess and this is strictly conjecture Mr. Thompson Jr. or Sr. whatever anyone i.e. a long or a short can bring about a complaint to your office that might warrant an investigation? I am certain if you do your homework Zonagen has
neither confirmation of a patent nor has filed for an NDA. People have invested because they believe that the above will be approved. You don't win them all especially if you are a short.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext